Intraluminal autocrine purinergic signaling within cysts: Implications for the progression of diseases that involve encapsulated cyst formation

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 1, 2007, Pages

  Olteanu, Dragos ^a   Hovater, Michael B ^a   Schwiebert, Erik M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOSIDE; NUCLEOTIDE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

AUTOCRINE EFFECT; BREAST CYST; CELL CULTURE; DISEASE COURSE; EDITORIAL; ENCAPSULATION; ENZYME ACTIVATION; HUMAN; KIDNEY CELL; KIDNEY POLYCYSTIC DISEASE; MICROENVIRONMENT; NONHUMAN; OVARY CYST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 33846243855     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00291.2006     Document Type: Editorial

References (75)

1. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475, 1994.
2. Amstrup J, Novak I. P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of calcium influx. Biochem J 374: 51-61, 2003.
3. Boese SH, Glanville M, Aziz O, Gray MA, Simmons NL. Calcium and cyclic AMP-activated chloride conductances mediate chloride secretion in a mouse renal inner medullary collecting duct cell line. J Physiol 523: 325-338, 2000.
4. Braunstein GM, Zsembery A, Tucker TA, Schwiebert EM. Purinergic signaling underlies CFTR control of human airway epithelial cell volume. J Cystic Fibrosis 3: 99-117, 2004.
5. Burnstock G. Purinergic nerves. Pharmacol Rev 24: 509-581, 1972.
6. Burnstock G. Introductory editorial. Purinergic Signalling 1: 1-2, 2005.
7. Burnstock G. . Purinergic signaling. Br. J Pharmacol 147: S172-S181, 2006.
8. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58: 58-86, 2006.
9. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27: 166-176, 2006.
10. Burnstock G, Campbell G, Satchell D, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40: 668-688, 1970.
11. Calvet JP, Grantham JJ. The genetics and physiology of polycystic kidney disease. Semin Nephrol 21: 107-123, 2001.
12. Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with specific reference to their action upon the mammalian heart. J Physiol 68: 213-237, 1929.
13. Edwin F, Wiepz GJ, Singh R, Peet CR, Chaturvedi D, Bertics PJ, Patel TB. A historical perspective of the EGF receptor and related systems. Methods Mol Biol 327: 1-24, 2006.
14. Erb L, Liao Z, Seye CI, Weisman GA. P2 receptors: intracellular signaling. Pflügers Arch 452: 552-562, 2006.
15. Gonzalez-Perret S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD) is a calcium-permeable nonselective cation channel. Proc Natl Acad Sci USA 98: 1182-1187, 2001.
16. Gordon JL. Extracellular ATP: Effect, sources and fates. Biochem J 233: 309-319, 1986.
17. Grantham JJ. Polycystic kidney disease: from the bedside to the gene and back. Curr Opin Nephrol Hypertens 10: 533-542, 2001.
18. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 285: F1034-F1049, 2003.
19. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111: 1072-1080, 2003.
20. Hanaoka K, Devuyst O, Schwiebert EM, Wilson PD, Guggino WB. A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol Cell Physiol 270: C389-C399, 1996.
21. Hanaoka K, Guggino WB. Cyclic AMP regulates cell proliferation and cyst formation in autosomal dominant polycystic kidney disease cells. J Am Soc Nephrol 11: 1179-1187, 2000.
22. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG. Co-assembly of polycystin-1 and polycystin-2 produces unique cation-permeable currents. Nature 408: 990-994, 2000.
23. Harris PC. Molecular basis of polycystic kidney disease: PKD1, PKD2, and PKHD1. Curr Opin Nephrol Hypertens 11: 309-314, 2002.
24. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151-160, 1995.
25. Hurley DK, Bandy SM, Glew RH, Morris DM, Gardner KD. Kidney and breast cysts: a comparative study of fluids. Nephron 77: 304-308, 1997.
26. Ishikawa S, Higashiyama M, Kusaka I, Saito T, Nagasaka S, Fukuda S. Extracellular ATP promotes cellular growth of renal inner medullary collecting duct cells mediated by P2U receptors. Nephron 76: 208-214, 1997.
27. Jacobsen KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264, 2006.
28. Kizer NL, Lewis B, Stanton BA. Electrogenic sodium absorption and chloride secretion by an inner medullary collecting duct cell line (mIMCD-K2). Am J Physiol Renal Fluid Electrolyte Physiol 268: F347-F355, 1995.
29. Kizer NL, Vandorpe D, Lewis B, Bunting B, Russell J, Stanton BA. Vasopressin and cyclic AMP stimulate electrogenic chloride secretion in an IMCD cell line. Am J Physiol Renal Fluid Electrolyte Physiol 268: F854-F861, 1995.
30. Knowles MR, Clarke LL, Boucher RC. Activation of extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325: 533-538, 1991.
31. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4: 191-197, 2002.
32. Luo Y, Vassilev PM, Li X, Kawanabe Y, Zhou J. Native polycystin-2 functions as a plasma membrane calcium-permeable cation channel in renal epithelia. Mol Cell Biol 23: 2600-2607, 2003.
33. Luo X, Zheng W, Yan M, Lee MG, Muallem S. Multiple functional P2X and P2Y receptors in the luminal and basolateral membranes of pancreatic duct cells. Am J Physiol Cell Physiol 277: C205-C215, 1999.
34. Mangoo-Karim R, Uchic ME, Grant M, Shumate WA, Calvet JP, Park CH, Grantham JJ. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J 3: 2629-2632, 1989.
35. Mangoo-Karim R, Ye M, Wallace DP, Grantham JJ, Sullivan LP. Anion secretion drive fluid secretion by monolayers of cultured human polycystic kidney cells. Am J Physiol Renal Fluid Electrolyte Physiol 269: F381-F388, 1995.
36. McCoy DE, Taylor AL, Kudlow BA, Karlson KH, Slattery MJ, Schwiebert LM, Schwiebert EM, Stanton BA. Nucleotides regulate NaCl transport across mIMCD-K2 cells via P2X and P2Y purinergic receptors. Am J Physiol Renal Physiol 277: F552-F559, 1999.
37. Morelli A, Chiozzi P, Chiesa A, Ferrari D, Sanz JM, Falzoni S, Pinton P, Rizzuto R, Olson MF, Di Virgilio F. Extracellular ATP causes ROCK-1 dependent bleb formation in P2X7-transfected HEK293 cells. Mol Biol Cell 14: 2655-2664, 2003.
38. Nandigama R, Padmasekar M, Wartenberg M, Sauer H. Feed forward cycle of hypotonic stress-induced ATP release, purinergic receptor activation, and growth stimulation of prostate cancer cells. J Biol Chem 281: 5686-5693, 2006.
39. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129-137, 2003.
40. Newby LJ, Streets AJ, Zhao Y, Harris PC, Ward CJ, Ong AC. Identification, characterization, and localization of a novel kidney polycystin-1/polycystin-2 complex. J Biol Chem 277: 20763-20773, 2002.
41. North RA. Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067, 2002.
42. Orellana SA, Sweeney WE, Neff CD, Avner ED. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47: 490-499, 1995.
43. Pazour GJ, Rosenbaum JL. Intraflagellar transport and cilia-dependent diseases. Trends Cell Biol 12: 551-555, 2002.
44. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG. PKD1 interacts with PKD2 through a coiled-coil domain. Nat Genet 16: 179-183, 1997.
45. Richards WG, Sweeney WE, Yoder BK, Wilkinson JE, Woychik RP, Avner ED. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 101: 935-939, 1998.
46. Schulze-Lohoff E, Zanner S, Ogilvie A, Sterzel RB. Extracellular ATP stimulates proliferation of cultured mesangial cells via P2 purinergic receptors. Am J Physiol Renal Fluid Electrolyte Physiol 263: F374-F383, 1992.
47. Schwiebert EM, Kishore BK. Extracellular purinergic signaling along the renal epithelium. Am J Physiol Renal Physiol 280: F945-F963, 2001.
48. Schwiebert EM. ATP release mechanisms, ATP receptors, and purinergic regulation along the nephron. Clin Exp Pharmacol Physiol 28: 340-350, 2001.
49. Schwiebert EM, Liang L, Cheng NL, Olteanu D, Richards Williams C, Welty EA, Zsembery A. Extracellular ATP- and zinc-gated P2X receptor calcium entry channels: physiological sensors and therapeutic targets. Purinergic Signalling 1: 299-310, 2005.
50. Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J, Hanaoka K, Guggino WB, Guay-Woodford LM, Bell PD, Sullivan LP, Grantham JJ, Taylor AL. A detrimental autocrine and paracrine purinergic signaling loop exists in epithelial cells derived from polycystic kidneys. Am J Physiol Renal Physiol 282: F763-F775, 2002.
51. Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochim Biophys Acta 1615: 7-32, 2003.
52. Simmons NL. Renal epithelial chloride secretion. Exp Physiol 78: 117-137, 1993.
53. Simmons NL. Identification of a purine (P2) receptor linked to ion transport in a cultured renal (MDCK) epithelium. Br J Pharmacol 73: 379-384, 1981.
54. Simmons NL. Stimulation of chloride secretion by exogenous ATP in cultured MDCK epithelial monolayers. Biochim Biophys Acta 646: 231-242, 1981.
55. Stewart GS, Glanville M, Aziz O, Simmons NL, Gray MA. Regulation of an outwardly rectifying chloride conductance in renal epithelial cells by external and internal calcium. J Membr Biol 180: 49-64, 2001.
56. Stutts MJ, Fitz JG, Paradiso AM, Boucher RC. Multiple modes of regulation of airway epithelial chloride secretion by extracellular ATP. Am J Physiol Cell Physiol 267: C1442-C1451, 1994.
57. Sullivan LP, Wallace DP, Grantham JJ. Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 9: 903-916, 1998.
58. Sullivan LP, Wallace DP, Grantham JJ. Epithelial transport in polycystic kidney disease. Physiol Rev 78: 1165-1191, 1998.
59. Sutters M, Germino GG. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 141: 91-101, 2003.
60. Takeda M, Kobayashi M, Endou H. Establishment of a mouse clonal early proximal tubule cell line and outer medullary collecting duct cells expressing P2 purinoceptors. Biochem Mol Biol Int 44: 657-664, 1998.
61. Taylor AL, Kudlow BA, Marrs KL, Gruenert DC, Guggino WB, Schwiebert EM. Bioluminescence detection of ATP release mechanisms in epithelia. Am J Physiol Cell Physiol 275: C1391-C1406, 1998.
62. Taylor AL, Schwiebert LM, Smith JJ, King C, Jones JR, Sorscher EJ, Schwiebert EM. Epithelial P2X purinergic receptor channel expression and function. J Clin Invest 104: 875-884, 1999.
63. Turner CM, King BF, Srai KS, Unwin RJ. Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am J Physiol Renal Physiol 292: F15-F25, 2007.
64. Turner CM, Vonend O, Chan C, Burnstock G, and Unwin RJ. The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 175: 105-117, 2003.
65. Weisman GA, Wang M, Kong Q, Chorna NE, Neary JT, Sun GY, Gonzalez FA, Seye CI, Erb L. Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol Neurobiol 31: 169-183, 2005.
66. Wilson PD. Epithelial cell polarity and disease. Am J Physiol Renal Physiol 272: F434-F442, 1997.
67. Wilson PD. Polycystin: new aspects of structure, function, and regulation. J Am Soc Nephrol 12: 834-845, 2001.
68. Wilson PD. The genes and proteins associated with polycystic kidney diseases. Minerva Urol Nefrol 54: 201-211, 2002.
69. Wilson PD, Du J, Norman JT. Autocrine, paracrine and endocrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 61: 131-138, 1993.
70. Wilson PD, Hovater JS, Casey CC, Fortenberry JA, Schwiebert EM. ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J Am Soc Nephrol 10: 218-229, 1999.
71. Wu G, Somlo S. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol Genet Metab 69: 1-15, 2000.
72. Yoder BK, Hou X, and Guay-Woodford LM. The polycystic kidney disease proteins polycystin-1, polycystin-2, Polaris, and cystin are colocalized in renal cilia. J Am Soc Nephrol 13: 2508-2516, 2002.
73. Zhang Q, Taulman PD, Yoder BK. Cystic kidney disease: all roads lead to the cilium. Physiology (Bethesda) 19: 225-230, 2004.
74. Zsembery A, Boyce AT, Liang L, Peti-Peterdi J, Bell PD, Schwiebert EM. Sustained calcium entry through P2X nucleotide receptor channels in human airway epithelial cells. J Biol Chem 278: 13398-13408, 2003.
75. Zsembery A, Fortenberry JA, Liang L, Bebok Z, Tucker TA, Boyce AT, Braunstein GM, Welty EA, Bell PD, Sorscher EJ, Clancy JP, Schwiebert EM. Extracellular zinc and ATP restore chloride secretion across cystic fibrosis airway epithelia by triggering calcium entry. J Biol Chem 279: 10720-10729, 2004.